Shannon N. Westin

Oncology

210 Ashville Ave # 408
Cary, NC 27518

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 233 publications

Plain language summary of results from the DUO-E study: durvalumab given with or without olaparib in patients with advanced endometrial cancer.

Plain language summary of results from the DUO-E study: durvalumab given with or without olaparib in patients with advanced endometrial cancer.

Journal: Future oncology (London, England)

Published: April 07, 2026

Cadonilimab for recurrent small cell neuroendocrine carcinoma of the cervix: a phase 2 study.

Cadonilimab for recurrent small cell neuroendocrine carcinoma of the cervix: a phase 2 study.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: April 02, 2026

Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination-deficient stage III/IV ovarian cancer: Findings from cohort C of the OPAL phase 2 trial.

Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination-deficient stage III/IV ovarian cancer: Findings from cohort C of the OPAL phase 2 trial.

Journal: Gynecologic oncology

Published: March 04, 2026

Endometrial cancer: A Society of Gynecologic Oncology evidence-based review and recommendations: Part I.

Endometrial cancer: A Society of Gynecologic Oncology evidence-based review and recommendations: Part I.

Journal: Gynecologic oncology

Published: February 09, 2026

Endometrial cancer: A Society of Gynecologic Oncology evidence-based review and recommendations, part II.

Endometrial cancer: A Society of Gynecologic Oncology evidence-based review and recommendations, part II.

Journal: Gynecologic oncology

Published: February 09, 2026

Oral cyclophosphamide combined with bevacizumab in recurrent heavily pre-treated ovarian cancer.

Oral cyclophosphamide combined with bevacizumab in recurrent heavily pre-treated ovarian cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: January 13, 2026

Phase II Trial of Ribociclib Plus Letrozole in Women With Recurrent Low-Grade Serous Carcinoma of the Ovary, Fallopian Tube, or Peritoneum: A GOG Partners Trial (GOG 3026).

Phase II Trial of Ribociclib Plus Letrozole in Women With Recurrent Low-Grade Serous Carcinoma of the Ovary, Fallopian Tube, or Peritoneum: A GOG Partners Trial (GOG 3026).

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: December 12, 2025

Biomarker heterogeneity and efficacy of durvalumab plus carboplatin/paclitaxel followed by durvalumab with or without olaparib in patients with mismatch repair proficient endometrial cancer: exploratory analyses of the DUO-E/GOG-3041/ENGOT-EN10 trial.

Biomarker heterogeneity and efficacy of durvalumab plus carboplatin/paclitaxel followed by durvalumab with or without olaparib in patients with mismatch repair proficient endometrial cancer: exploratory analyses of the DUO-E/GOG-3041/ENGOT-EN10 trial.

Journal: Gynecologic oncology

Published: November 28, 2025

First-In-Human Trial of Encapsulated Cell-Based Protein Producers for Localized IL-2 in Patients with High-Grade Serous Ovarian Carcinoma.

First-In-Human Trial of Encapsulated Cell-Based Protein Producers for Localized IL-2 in Patients with High-Grade Serous Ovarian Carcinoma.

Journal: medRxiv : the preprint server for health sciences

Published: November 26, 2025

First-In-Human Trial of Encapsulated Cells Constitutively Expressing Localized IL2 in Patients with High-Grade Serous Ovarian Carcinoma.

First-In-Human Trial of Encapsulated Cells Constitutively Expressing Localized IL2 in Patients with High-Grade Serous Ovarian Carcinoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: November 14, 2025

Levonorgestrel-releasing intrauterine system treatment for endometrial hyperplasia and early endometrial cancer: a systematic review.

Levonorgestrel-releasing intrauterine system treatment for endometrial hyperplasia and early endometrial cancer: a systematic review.

Journal: Therapeutic advances in reproductive health

Published: October 23, 2025

Correlation of BRCA and homologous recombination deficiency status with clinical and survival outcomes in patients with advanced-stage ovarian cancer undergoing frontline therapy.

Correlation of BRCA and homologous recombination deficiency status with clinical and survival outcomes in patients with advanced-stage ovarian cancer undergoing frontline therapy.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: October 17, 2025

Showing 1-12 of 233

Last Updated: 09/26/2026